Insider filing · MDGL
Shannon T Kelley
General Counsel
profile →
Madrigal Pharmaceuticals, Inc.
MDGL · Healthcare · 60 filings in 24 months
ticker →
Shannon T Kelley sold $431K of Madrigal Pharmaceuticals (MDGL)
Executed Nov 6, disclosed Nov 6, the same day.
Value, as filed
$431K
1,077 sh × $400.00
Executed
Nov 6
the trade date, as filed
Disclosed
Nov 6
0 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
SKShannon T Kelley (General Counsel) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales, 1 filed past the two-business-day deadline), most often in Madrigal Pharmaceuticals, Inc. (MDGL). The largest single filing was $431K of MDGL (1,077 sh × $400.00, as filed), executed Nov 6.
The name
MDGLHealthcare · Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Shannon T Kelley in MDGL
MDGLSALE
Madrigal Pharmaceuticals, Inc.
$342K664 sh × $514.97
Exec Aug 17
Filed Aug 20 · 4:20 PM ET † MDGLSALE Madrigal Pharmaceuticals, Inc. $155K
360 sh × $431.94
Exec Mar 6
Filed Mar 6 · 5:30 PM ET MDGLSALE Madrigal Pharmaceuticals, Inc. $344K
692 sh across 2 lots
Exec Jan 20
Filed Jan 20 · 5:30 PM ET MDGLSALE Madrigal Pharmaceuticals, Inc. $164K
458 sh × $358.66
Exec Aug 18 2025
Filed Aug 18 2025 · 5:30 PM ET MDGLSALE Madrigal Pharmaceuticals, Inc. $139K
415 sh × $335.00
Exec Mar 3 2025
Filed Mar 5 2025 · 5:30 PM ET